Expedeon AG buy fenjal
Start price
29.04.08
/
50%
€38.40
Target price
14.05.08
€40.80
Performance (%)
15.00%
End price
14.05.08
€44.16
Summary
This prediction ended on 14.05.08 with a price of €44.16. The prediction had a final performance of 15.00%. fenjal has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Expedeon AG | - | - | - | - |
iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by fenjal for this prediction
In the thread Expedeon AG diskutieren
Sygnis Pharma ehemals Lion Bioscience
Totgesagte leben länger...
"Heidelberg, 24. April 2008 – Die SYGNIS Pharma AG (...), hat von der Europäischen Kommission die Orphan Drug Designation für den Wirkstoff AX200 zur Behandlung der Amyotrophen Lateral-sklerose (ALS) erhalten."
Quelle: www.sygnis.de/presse_und_medien/pressemitteilungen/2008_04_24/index_ger.html
(Vom Mitglied beendet)